Publication | Closed Access
Genetically engineered Newcastle disease virus expressing interleukin 2 is a potential drug candidate for cancer immunotherapy
40
Citations
41
References
2014
Year
Potential Drug CandidateInterleukin 2ImmunologyBiological TherapyGene VectorImmunotherapyMedicineRadiation OncologyNovel TherapyNewcastle Disease VirusViral OncologySynthetic Immunology
| Year | Citations | |
|---|---|---|
Page 1
Page 1